CD138 Polyclonal Antibody
产品特性
| Product Cat#: | 36-2900 |
| Product type: | Primary antibody |
| Antigen: | CD138 |
| Immunogen: | Synthetic peptide derived from an internal region of the human Syndecan-1 protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | WB; IHC (P); ELISA |
| Reactivity: | Mouse, Rat and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | PBS, pH 7.4, 0.1% sodium azide |
| Concentration: | 0.25 mg/mL |
| Purity: | Antigen affinity chromatography |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CD_antigen antibody |
| CD138 antibody | |
| CD138 antigen antibody | |
| heparan sulfate proteoglycan fibroblast growth factor receptor antibody | |
| SDC antibody | |
| Sdc1 antibody | |
| SDC1_HUMAN antibody | |
| SYND1 antibody | |
| Syndecan 1 antibody | |
| Syndecan antibody | |
| syndecan proteoglycan 1 antibody | |
| Syndecan-1 antibody |
靶标信息
Cell surface proteoglycan that contains both heparan sulfate and chondroitin sulfate and that links the cytoskeleton to the interstitial matrix (By similarity).
Regulates exosome biogenesis in concert with SDCBP and PDCD6IP (PubMed:22660413).
Able to induce its own expression in dental mesenchymal cells and also in the neighboring dental epithelial cells via an MSX1-mediated pathway (By similarity).
相关文献
1、Viktorsson K, Hååg P, Shah CH, Franzén B, Arapi V, Holmsten K, Sandström P, Lewensohn R, Ullén A. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome. Mol Oncol. 2022 Oct;16(20):3620-3641. doi: 10.1002/1878-0261.13288. Epub 2022 Aug 12. PMID: 35838333; PMCID: PMC9580890.
2、Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E, Gualtierotti R, Mazzaccaro D, La Sala G, Di Pietro C, Palizban M, Liuni S, DePedro G, Morara S, Nano G, Kehler J, Greve B, Noghero A, Marazziti D, Bussolino F, Bellipanni G, D’Agnano I, Götte M, Zucchi I, Reinbold R. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Front Cell Neurosci. 2021 Nov 17;15:703431. doi: 10.3389/fncel.2021.703431. PMID: 34867197; PMCID: PMC8636015.
3、van de Vlekkert D, Qiu X, Annunziata I, d’Azzo A. Isolation and Characterization of Exosomes from Skeletal Muscle Fibroblasts. J Vis Exp. 2020 May 16;(159):10.3791/61127. doi: 10.3791/61127. PMID: 32478721; PMCID: PMC8186027.
